Home › Portfolio Model Subscription › SwissMedic Approval of Lonza (LONN-SW, $587.40 CHF) Facilities Will Determine Moderna (MRNA-NYSE, $132.04) Vaccine Output for 2021.

SwissMedic Approval of Lonza (LONN-SW, $587.40 CHF) Facilities Will Determine Moderna (MRNA-NYSE, $132.04) Vaccine Output for 2021.

Posted on January 15, 2021 by Randolph McDuff — No Comments ↓

https://finance.yahoo.com/news/lonza-awaits-licence-swiss-plant-104059985.html

Posted in Portfolio Model Subscription

Leave a Reply

Recent Comments
    Archives